StockHong KongNasdaqCM

RGC

Regencell Bioscience Holdings Limited

Healthcare · Drug Manufacturers - Specialty & Generic

5.85USD

-0.9700 (-14.22%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End06/2025

Last Quarter End12/2025 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 5.85

P/E—

Dvd Ind Yld—

P/B2,925.00

P/S—

Curr EV/T12M EBITDA-409.1

Mkt Cap (USD)—

Curr EV (USD)2.9B

Per Share Data

EPS T12M-0.01

DPS—

Bk Val Per Sh0.00

Rev/Sh—

Cash/Sh0.01

Curr Shares Out494.5M

FCF/Sh-0.01

Cash Flow Analysis

P/CF—

Curr P/FCF—

CF/NI0.9

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales—

Eff Interest Rate—

Growth Potential

Dil EPS 1Y Gr17.2%

Cap 1Y Gr-31.7%

BPS 1Y Gr-31.7%

R&D To Sales—

Retention Rate100.0%

Rev 1Y Gr—

FCF 1Y Gr19.7%

Assets 1Y Gr-33.1%

Profitability

EBITDA-0.0B

EBIT-0.0B

Operating Margin0.0%

Pretax Margin—

Net Margin0.0%

ROA-40.9%

ROE-47.1%

ROC—

Asset Turnover—

Structure

Current Ratio12.18

Quick Ratio1.42

Debt/Assets12.8%

Debt/Com Eq31.7%

Net Debt/EBITDA0.65

Tot Debt/Capital24.1%

Gross Margin0.0%

EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.